INT Medical Announces FY2025 Final Dividend of RMB0.23 per Share, Payable on 30 June 2026

Bulletin Express

03/27

Shanghai INT Medical Instruments Co., Ltd. (INT Medical) declared a final ordinary cash dividend of RMB 0.23 per share for the financial year ended 31 December 2025. Based on the fixed exchange rate of RMB 1: HKD 1.135, shareholders registered in Hong Kong will receive HKD 0.26 per share.

Shareholders’ approval is scheduled for 28 May 2026. The stock will trade ex-dividend on 3 June 2026, with the share register closing from 5 June to 10 June 2026. The record date is set at 10 June 2026, and dividend payments will be distributed on 30 June 2026 through Computershare Hong Kong Investor Services Limited.

Dividend withholding tax will be applied according to shareholder classification: non-resident enterprises at 10%, non-resident individuals at 10% when covered by an applicable tax treaty, and 20% for resident individuals from jurisdictions without such agreements.

As of the announcement date, INT Medical’s board consists of two executive directors, four non-executive directors, and three independent non-executive directors.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1150687272"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150687272\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150687272?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150687272","market":"us","top_or_hot":-1,"title":"INT Medical Announces FY2025 Final Dividend of RMB0.23 per Share, Payable on 30 June 2026","media":"Bulletin Express","content":"<p>Shanghai INT Medical Instruments Co., Ltd. (INT Medical) declared a final ordinary cash dividend of RMB 0.23 per share for the financial year ended 31 December 2025. Based on the fixed exchange rate of RMB 1: HKD 1.135, shareholders registered in Hong Kong will receive HKD 0.26 per share.</p>\n<p>Shareholders’ approval is scheduled for 28 May 2026. The stock will trade ex-dividend on 3 June 2026, with the share register closing from 5 June to 10 June 2026. The record date is set at 10 June 2026, and dividend payments will be distributed on 30 June 2026 through Computershare Hong Kong Investor Services Limited.</p>\n<p>Dividend withholding tax will be applied according to shareholder classification: non-resident enterprises at 10%, non-resident individuals at 10% when covered by an applicable tax treaty, and 20% for resident individuals from jurisdictions without such agreements.</p>\n<p>As of the announcement date, INT Medical’s board consists of two executive directors, four non-executive directors, and three independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INT Medical Announces FY2025 Final Dividend of RMB0.23 per Share, Payable on 30 June 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINT Medical Announces FY2025 Final Dividend of RMB0.23 per Share, Payable on 30 June 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-27 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai INT Medical Instruments Co., Ltd. (INT Medical) declared a final ordinary cash dividend of RMB 0.23 per share for the financial year ended 31 December 2025. Based on the fixed exchange rate of RMB 1: HKD 1.135, shareholders registered in Hong Kong will receive HKD 0.26 per share.</p>\n<p>Shareholders’ approval is scheduled for 28 May 2026. The stock will trade ex-dividend on 3 June 2026, with the share register closing from 5 June to 10 June 2026. The record date is set at 10 June 2026, and dividend payments will be distributed on 30 June 2026 through Computershare Hong Kong Investor Services Limited.</p>\n<p>Dividend withholding tax will be applied according to shareholder classification: non-resident enterprises at 10%, non-resident individuals at 10% when covered by an applicable tax treaty, and 20% for resident individuals from jurisdictions without such agreements.</p>\n<p>As of the announcement date, INT Medical’s board consists of two executive directors, four non-executive directors, and three independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01501","symbol_name":"瑛泰医疗","start_time":0,"source_url":"","article_id":"1150687272","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150687272","pubTimestamp":1774613076,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai INT Medical Instruments Co., Ltd. (INT Medical) declared a final ordinary cash dividend of RMB 0.23 per share for the financial year ended 31 December 2025. Based on the fixed exchange rate...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01501":"瑛泰医疗"},"translate_title":"英特医疗宣布派发2025财年末期股息每股人民币0.23元，将于2026年6月30日派发","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01501":1},"content_text":"Shanghai INT Medical Instruments Co., Ltd. (INT Medical) declared a final ordinary cash dividend of RMB 0.23 per share for the financial year ended 31 December 2025. Based on the fixed exchange rate of RMB 1: HKD 1.135, shareholders registered in Hong Kong will receive HKD 0.26 per share.\nShareholders’ approval is scheduled for 28 May 2026. The stock will trade ex-dividend on 3 June 2026, with the share register closing from 5 June to 10 June 2026. The record date is set at 10 June 2026, and dividend payments will be distributed on 30 June 2026 through Computershare Hong Kong Investor Services Limited.\nDividend withholding tax will be applied according to shareholder classification: non-resident enterprises at 10%, non-resident individuals at 10% when covered by an applicable tax treaty, and 20% for resident individuals from jurisdictions without such agreements.\nAs of the announcement date, INT Medical’s board consists of two executive directors, four non-executive directors, and three independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}